Van Der Windt. (2017). Can we identify who gets benefit or harm from mycophenolate mofetil in systemic lupus erythematosus? a systematic review. Seminars in Arthritis and Rheumatism, 65-78. https://doi.org/10.1016/j.semarthrit.2017.01.009